Combination, therapeutic uses and prophylactic uses
AssigneeQuantec Limited
InventorsJudith Mary Bragger, Rodney Wayne Claycomb, Colin Roger Ogle
Life of this patent
Estimating the term…
Abstract
This invention relates to the therapeutic and prophylactic use of a combination including lactoperoxidase and at least one other component, with an isoelectric point of, or substantially above 6.8, and which are extracted from milk, to modulate the microbiome of an animal by selectively against at least one pathogenic microoganism.
Claims13
A method of modulating a microbiome by selectively inhibiting growth or killing pathogenic micro-organism Streptococcus pyogenes without a comparative inhibition of at least one commensal micro-organism, the method comprising the step of administering to a human tissue including a microbiome a combination including:
- lactoperoxidase present at a minimum amount of at least 5% w/w;
- angiogenin;
- lactoferrin;
- lysozyme-like protein;
- quiescin;
- and
- jacalin-like protein,
- wherein the lactoperoxidase, angiogenin, lactoferrin, lysozyme-like protein, quiescin, and jacalin-like protein all have an isoelectric point of or above 6.8 and are extracted from milk from a non-human species.
Dependencies are inferred from the claim text.